Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7158865 | 1.00 | EPHX1 (0.37) | EPHX1LMNA | |
| SCHEMBL11151418 | 0.98 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL9240555 | 0.92 | EPHX1 (0.31) | EPHX1 | |
| Sulfuric Acid SCHEMBL11155074 | 0.89 | TP53 (0.40) | — | |
| SCHEMBL7156018 | 0.88 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL7153066 | 0.88 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL5690449 | 0.84 | EPHX1 (0.36) | EPHX1 | |
| SCHEMBL9658998 | 0.75 | THRB (0.33) | — | |
| SCHEMBL19333960 | 0.74 | EPHX1 (0.41) | EPHX1LMNA | |
| SCHEMBL18886902 | 0.74 | ALDH1A1 (0.46) | EPHX1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024135300-A1 | COSMETIC COMPOSITION, COSMETIC COMPOSITION FOR SUPPRESSING DISCOLORATION, AND DISCOLORATION SUPPRESSANT | 株式会社資生堂 | 2024-06-27 | — | — | WO | disclosed |
| CN-118251204-A | Cosmetic product | 株式会社资生堂 | 2024-06-25 | — | — | CN | disclosed |
| CN-116916879-A | Cosmetic product | 株式会社资生堂 | 2023-10-20 | — | — | CN | disclosed |
| CN-116916880-A | Cosmetic product | 株式会社资生堂 | 2023-10-20 | — | — | CN | disclosed |
| CN-116456953-A | Water-in-oil type emulsified cosmetic | 株式会社资生堂 | 2023-07-18 | — | — | CN | disclosed |
| CN-107106468-B | Nanoemulsion emulsifying composition, bicontinuous microemulsion, cosmetic and preparation method thereof | 日油株式会社 | 2020-02-14 | — | — | CN | disclosed |
| US-20140100327-A1 | (METH)ACRYLIC ACID-BASED COPOLYMER | SUMITOMO SEIKA CHEMICALS CO., LTD. (JP) | 2014-04-10 | — | — | US | disclosed |
| EP-1604647-B1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | CHISSO CORP (JP) | 2008-05-07 | — | — | EP | disclosed |
| US-20060018867-A1 | Cosmetic composition and production thereof | ICHIMARU PHARCOS CO., LTD | 2006-01-26 | — | — | US | disclosed |
| EP-1604647-A1 | Cosmetic composition containing polyorganosiloxane-containing epsilon-polylysine polymer, and polyhydric alcohol, and production thereof | Ichimaru Pharcos Co., Ltd. (JP) | 2005-12-14 | — | — | EP | disclosed |
| EP-0945452-B1 | SUGAR COMPOUNDS, GELLING AGENTS, GELLING AGENT COMPOSITIONS, PROCESSES FOR THE PREPARATION OF THEM, AND GEL COMPOSITIONS | NEW JAPAN CHEM CO LTD (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-6187842-B1 | REACTING SORBITOL OR XYLITOL WITH BENZALDEHYE IN PRESENCE OF ACID CATALYST | NEW JAPAN CHEMICAL CO., LTD. (JP) | 2001-02-13 | — | — | US | disclosed |
| EP-0945452-A1 | SUGAR COMPOUNDS, GELLING AGENTS, GELLING AGENT COMPOSITIONS, PROCESSES FOR THE PREPARATION OF THEM, AND GEL COMPOSITIONS | NEW JAPAN CHEMICAL CO.,LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060018867-A1 | Cosmetic composition and production thereof | CUTA, PARG, TYR | EPHX1 2769/4885LMNA 142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.